Does vitamin D ward off coronavirus? Don't reach for the supplements yet
Americans' Biggest Financial Regret Is Not Saving Enough Before The Coronavirus Hit
COVID-19: Bacteriophage could decrease mortality
We Are In The Winter of Household Finances.
Pluristem Is a High Risk, High Reward Play, Says Jefferies Analyst
Cancer drug cures COVID-19 patient with acute respiratory distress
Cipla launches COVID-19 drug remdesivir in India as disease takes hold
UK team awarded grant for ‘second wave’ COVID-19 drug hunt
Mixed results for Roche drugs in prostate cancer and COVID-19
US cities with pro sports see more flu deaths
Coronavirus pharma news roundup – 19/06/20
Fighting the COVID-19 pandemic through testing
2 “Strong Buy” Small-Cap Stocks That Could See Outsized Gains
US left with huge hydroxychloroquine stockpile after COVID-19 trial failures
Rural America is more vulnerable to COVID-19 than cities are, and it's starting to show
Gilead will test remdesivir in children with COVID-19
Sweden Says Herd Immunity "Surprisingly Slow" To Develop Despite Avoiding Lockdowns
Ron Paul: Is The "Second Wave" Another COVID-19 Hoax?
Fred Hutch and University of Washington experts: Treat COVID-19 earlier to save lives
UK stops recruitment to hydroxychloroquine COVID-19 trials
TERAVOLT registry tracks outcomes among thoracic cancer patients sickened by COVID-19
Herd immunity won’t solve our COVID-19 problem
In the future, your phone could test you for coronavirus – here's how
Beijing Bars 'High Risk' Residents From Leaving, Closes 7 Compounds As Lockdowns Return
Mutation in new coronavirus increases chance of infection: study
Eli Lilly launches PhIII JAK study, aiming for the first drug to lower mortality in Covid-19
Coronavirus shows how ageism is harmful to health of older adults
Is a Second Wave coming?
Houston "On The Precipice Of Disaster" As Officials Weigh Reimposing Stay At Home Order Amid Spike In Cases: Live Updates
Promising path found for COVID-19 therapeutics